DMC
Xuất nhập khẩu Y Tế DOMESCO ·HOSE ·2026Q1
▼ Under pressure
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, DMC is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — profit momentum has been slowing across consecutive periods. What remains unclear is whether the business can stabilize before this trend deepens.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 519.6 | 559.0 | 528.9 | 510.3 | 469.1 | 570.5 | 448.1 | 461.7 | 419.2 | 468.9 | 444.9 | 399.7 |
| Growth | -7% | +6% | +4% | +9% | -18% | +27% | -3% | +10% | -11% | +5% | +11% | — |
| Net Income | 52.9 | 91.4 | 27.9 | 31.7 | 47.0 | 76.9 | 32.8 | 52.1 | 41.0 | 57.8 | 44.6 | 47.7 |
| Net Margin | 10.19% | 16.35% | 5.28% | 6.21% | 10.02% | 13.48% | 7.32% | 11.28% | 9.77% | 12.33% | 10.03% | 11.93% |
Drivers of DMC's profit
Net profit attributable to parent declined vs last year, mainly due to lower financial income. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by lower selling expenses. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 13.0% to 12.0% — leverage weakened the most, though asset turnover still provided support.
Is the profit sustainable?
Margins narrowed but earnings quality remains clean — pressure is mainly operational.
What is driving the margin?
Net margin narrowed to 9.63%, falling 1.1pp. The main pressure is Gross margin fell 1.8pp, outweighing the improvement in SG&A / Revenue fell 1.0pp (with lingering pressure from Net financial result / Revenue fell 0.5pp and Other profit / Revenue fell 0.0pp).
Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 0.13x equity, with a net cash position equivalent to 0.04x equity.
Inventory ended the period at 521.2bn, roughly 27.2% of total assets.
Over the last 12 months, working capital absorbed 14.9bn of cash, mainly because of higher inventories. Part of that drag was offset by lower receivables and higher payables.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Cash conversion cycle lengthened by 6.3 days versus the same period last year. The main moves came from DIO rose 9.5 days, DSO fell 23.4 days, and DPO fell 20.3 days.
Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.
Watchpoints
CCC stands at 179.8 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DIO increased by +9.5 days, suggesting more capital is being tied up in inventories.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 161.4bn.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at -0.04x and interest coverage at 41.07x.
Debt maturity and the cash buffer remain the two key areas to monitor.
Some leverage signals are missing, so the current read should be treated as contextual.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 161.4bn in 2025, against investing cash flow of -128.4bn.
Post-investment cash flow was positive +33.0bn. Financing cash flow was negative +86.8bn.
CFO / net income was 0.79x.
After spending +24.5bn on fixed-asset investment, the business generated trailing free cash flow of +136.9bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with working capital is tied up too long in the operating cycle remaining the main constraint, with CCC extended to 180 days. The next watchpoint is capital efficiency. The main offsetting support comes from earnings conversion is confirmed, with CFO/NI at 0.79x.
Improvement: earnings conversion looks more confirmed, with CFO / net income at 0.79x.
Watchpoint: Capital efficiency needs cycle context.
Key risk: working capital remains tied up for too long, with cash cycle at 179.8 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
2,067.3 | 1,899.4 | 1,719.0 | 1,592.7 | 1,498.4 |
|
Cost of Goods Sold
|
1,658.2 | 1,481.9 | 1,346.9 | 1,139.8 | 0.0 |
|
Gross Profit
|
409.1 | 417.5 | 372.1 | 452.9 | 401.6 |
|
Financial Expenses
|
6.3 | 6.1 | 5.2 | 10.1 | -2.9 |
|
Selling Expenses
|
109.0 | 113.7 | 113.7 | 146.2 | -144.9 |
|
General and Administrative Expenses
|
79.3 | 77.7 | 75.0 | 72.2 | -70.1 |
|
Operating Profit
|
244.4 | 249.6 | 222.5 | 247.9 | 198.0 |
|
Profit Before Tax
|
248.2 | 253.4 | 229.2 | 250.2 | 199.2 |
|
Net Income
|
198.4 | 202.7 | 183.3 | 200.1 | 159.3 |
|
Profit Attributable to Parent
|
198.4 | 202.7 | 183.3 | 200.1 | 159.3 |
|
Earnings per Share
|
4,856.00 | 4,962.00 | 4,487.00 | 5,761.00 | 4,588.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.